Published in Genetics and Environmental Business Week, September 11th, 2008
Evotec will be speaking on Monday 1st September at 16.50 (CET) leading the presentation sessions on Fragment Based Drug Discovery. Dr. John Barker, Group Leader of Structural Biology, will front the presentation about the design and implementation of EVOlution™, Evotec's fragment-based drug discovery platform (FBDD). This technology offers an innovative approach for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.